Works matching IS 08857490 AND DT 2022 AND VI 37 AND IP 3
Results: 23
Correction to: RNA as a Source of Biomarkers for Amyotrophic Lateral Sclerosis.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Alzheimer's disease therapy based on acetylcholinesterase inhibitor/blocker effects on voltage-gated potassium channels.
- Published in:
- Metabolic Brain Disease, 2022, v. 37, n. 3, p. 581, doi. 10.1007/s11011-022-00921-w
- By:
- Publication type:
- Article
Psychometric methods for diagnosing and monitoring minimal hepatic encephalopathy —current validation level and practical use.
- Published in:
- 2022
- By:
- Publication type:
- Literature Review
Plasma phosphorylated-tau181 levels reflect white matter microstructural changes across Alzheimer's disease progression.
- Published in:
- Metabolic Brain Disease, 2022, v. 37, n. 3, p. 761, doi. 10.1007/s11011-022-00908-7
- By:
- Publication type:
- Article
Sevoflurane represses the progression of glioma by the regulation of circ_0037655/miR-130a-5p/RPN2 axis.
- Published in:
- Metabolic Brain Disease, 2022, v. 37, n. 3, p. 787, doi. 10.1007/s11011-022-00906-9
- By:
- Publication type:
- Article
Effect of blueberry extract on energetic metabolism, levels of brain-derived neurotrophic factor, and Ca<sup>2+</sup>-ATPase activity in the hippocampus and cerebral cortex of rats submitted to ketamine-induced mania-like behavior.
- Published in:
- Metabolic Brain Disease, 2022, v. 37, n. 3, p. 835, doi. 10.1007/s11011-022-00904-x
- By:
- Publication type:
- Article
Regulation of microRNAs in Alzheimer´s disease, type 2 diabetes, and aerobic exercise training.
- Published in:
- 2022
- By:
- Publication type:
- Literature Review
A kinetic scheme to examine the role of glial cells in the pathogenesis of Alzheimer's disease.
- Published in:
- Metabolic Brain Disease, 2022, v. 37, n. 3, p. 801, doi. 10.1007/s11011-022-00902-z
- By:
- Publication type:
- Article
Knockdown of circ_0007290 alleviates oxygen-glucose deprivation-induced neuronal injury by regulating miR-496/PDCD4 axis.
- Published in:
- Metabolic Brain Disease, 2022, v. 37, n. 3, p. 807, doi. 10.1007/s11011-021-00900-7
- By:
- Publication type:
- Article
EIF4A3-induced circCCNB1 (hsa_circ_0001495) promotes glioma progression by elevating CCND1 through interacting miR-516b-5p and HuR.
- Published in:
- Metabolic Brain Disease, 2022, v. 37, n. 3, p. 819, doi. 10.1007/s11011-021-00899-x
- By:
- Publication type:
- Article
LncRNA NEAT1 ameliorate ischemic stroke via promoting Mfn2 expression through binding to Nova and activates Sirt3.
- Published in:
- Metabolic Brain Disease, 2022, v. 37, n. 3, p. 653, doi. 10.1007/s11011-021-00895-1
- By:
- Publication type:
- Article
Analysis of expression profiles and bioinformatics suggests that plasma exosomal circular RNAs may be involved in ischemic stroke in the Chinese Han population.
- Published in:
- Metabolic Brain Disease, 2022, v. 37, n. 3, p. 665, doi. 10.1007/s11011-021-00894-2
- By:
- Publication type:
- Article
Disorders of Tetrahydrobiopterin Metabolism: Experience from South India.
- Published in:
- Metabolic Brain Disease, 2022, v. 37, n. 3, p. 743, doi. 10.1007/s11011-021-00889-z
- By:
- Publication type:
- Article
Beneficial effects of levetiracetam in streptozotocin-induced rat model of Alzheimer's disease.
- Published in:
- Metabolic Brain Disease, 2022, v. 37, n. 3, p. 689, doi. 10.1007/s11011-021-00888-0
- By:
- Publication type:
- Article
A novel antagonist of TRPM2 and TRPV4 channels: Carvacrol.
- Published in:
- Metabolic Brain Disease, 2022, v. 37, n. 3, p. 711, doi. 10.1007/s11011-021-00887-1
- By:
- Publication type:
- Article
Evaluation of Styrylbenzene analog- FSB and its affinity to bind parenchymal plaques and tangles in patients of Alzheimer's disease.
- Published in:
- Metabolic Brain Disease, 2022, v. 37, n. 3, p. 639, doi. 10.1007/s11011-021-00885-3
- By:
- Publication type:
- Article
The brain neuropeptides and STAT3 mediate the inhibitory effect of 17-β Estradiol on central leptin resistance in young but not aged female high-fat diet mice.
- Published in:
- Metabolic Brain Disease, 2022, v. 37, n. 3, p. 625, doi. 10.1007/s11011-021-00884-4
- By:
- Publication type:
- Article
The association of stem cell factor and soluble c-Kit (s-cKit) receptor serum concentrations with the severity and risk prediction of autism spectrum disorders.
- Published in:
- Metabolic Brain Disease, 2022, v. 37, n. 3, p. 619, doi. 10.1007/s11011-021-00883-5
- By:
- Publication type:
- Article
Apelin–13 protects against memory impairment and neuronal loss, Induced by Scopolamine in male rats.
- Published in:
- Metabolic Brain Disease, 2022, v. 37, n. 3, p. 701, doi. 10.1007/s11011-021-00882-6
- By:
- Publication type:
- Article
LncRNA CEBPA-AS1 knockdown prevents neuronal apoptosis against oxygen glucose deprivation/reoxygenation by regulating the miR-455/GPER1 axis.
- Published in:
- Metabolic Brain Disease, 2022, v. 37, n. 3, p. 677, doi. 10.1007/s11011-021-00881-7
- By:
- Publication type:
- Article
Sesamol prevents mitochondrial impairment and pro-inflammatory alterations in the human neuroblastoma SH-SY5Y cells: role for Nrf2.
- Published in:
- Metabolic Brain Disease, 2022, v. 37, n. 3, p. 607, doi. 10.1007/s11011-021-00875-5
- By:
- Publication type:
- Article
Effect of Solanum vegetables on memory index, redox status, and expressions of critical neural genes in Drosophila melanogaster model of memory impairment.
- Published in:
- Metabolic Brain Disease, 2022, v. 37, n. 3, p. 729, doi. 10.1007/s11011-021-00871-9
- By:
- Publication type:
- Article
NMR based CSF metabolomics in tuberculous meningitis: correlation with clinical and MRI findings.
- Published in:
- Metabolic Brain Disease, 2022, v. 37, n. 3, p. 773, doi. 10.1007/s11011-021-00860-y
- By:
- Publication type:
- Article